NDC 59930-1575 - betamethasone dipropionate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59930-1575
- Package NDCs from labels
- 59930-1575-1, 59930-1575-3
- Manufacturer
- Warrick Pharmaceuticals Corporation
- Effective date
- 2006-12-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| betamethasone dipropionate - Warrick Pharmaceuticals Corporation | Warrick Pharmaceuticals Corporation | 2006-12-07 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59930-1575-1 | betamethasone dipropionate | 15 g in 1 TUBE | OINTMENT | 15 | 1 | |
| 59930-1575-1 | betamethasone dipropionate | 1 in 1 BOX | OINTMENT | 1 | 1 | |
| 59930-1575-3 | betamethasone dipropionate | 50 g in 1 TUBE | OINTMENT | 50 | 1 | |
| 59930-1575-3 | betamethasone dipropionate | 1 in 1 BOX | OINTMENT | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59930-1575 | BETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE) OINTMENT [WARRICK PHARMACEUTICALS CORPORATION] | 1 | 4 package rows | 20070126_686B528E-5480-4CAA-8FF4-B1BAAF5983EC.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | b5291e39-40a0-4362-9281-97f5fb4025d9 | 2026-05-11 | Warnings, Adverse reactions | 848180 |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 853399f8-95a7-41f3-80e7-7ed8e3ff1a5e | 2026-01-30 | Warnings, Adverse reactions | 848180 |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Prasco Laboratories | f5b50c00-cc6f-4296-a9ae-b16888cef4dd | 2025-11-19 | Warnings, Adverse reactions | 848180 |
| DIPROLENE | BETAMETHASONE DIPROPIONATE | Organon LLC | 0b9543ad-2ca7-430d-aef9-81c376dc2e6c | 2025-11-19 | Warnings, Adverse reactions | 848180 |
| Betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | Lupin Pharmaceuticals, Inc. | 216d5b7f-4236-4882-b899-be17cb1a1584 | 2025-11-13 | Warnings, Adverse reactions | 848180 |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | 018fcec3-bfb4-451c-9b54-d1fd389c2a44 | 2025-03-14 | Warnings, Adverse reactions | 848180 |
| BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | Burel Pharmaceuticals, LLC | c8bda9a8-4dec-4084-84e5-4b4623390bd8 | 2024-12-04 | Warnings, Adverse reactions | 848180 |
| BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | Aurobindo Pharma Limited | e0e0baea-1744-4708-bda7-4ab7783a3fb4 | 2024-06-05 | Warnings, Adverse reactions | 848180 |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Actavis Pharma, Inc. | af8317d7-b280-4f40-ad88-802f99d33d78 | 2023-02-14 | Warnings, Adverse reactions | 848180 |
| 686B528E-5480-4CAA-8FF4-B1BAAF5983EC | 686B528E-5480-4CAA-8FF4-B1BAAF5983EC | 2006-12-07 | Adverse reactions | 686B528E-5480-4CAA-8FF4-B1BAAF5983EC 686B528E-5480-4CAA-8FF4-B1BAAF5983EC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.